Skip to main content
. 2016 Apr 21;26(2):235–244. doi: 10.18865/ed.26.2.235

Table 3. Biochemistries among fasting participants, The Southwest Heart Mind Pilot Study.

Biochemistries, n=34a
Sodium, mM 138.1 (3.1)
Normal, 136-148 29 (85.3%)
Potassium, mM 4.3 (.5)
Normal, 3.5-5.1 32 (94.1%)
Chloride, mM 104.5 (4.2)
Normal, 98-108 27 (79.4%)
CO2, mM 24.7 (2.2)
Normal, 21-32 33 (97.1%)
Glucose, mg/dL 106.4 (25.5)
Normal, 60-100 17 (50%)
Impaired, 100-126 17 (50%)
Blood urinary nitrogen (BUN), mg/dL 18.9 (9.7)
Normal, 3-21 26 (76.5%)
Creatinine, mg/dL 1.2 (1.3)
Normal, .60-1.00 24 (70.6%)
Calcium, mg/dL 8.9 (.4)
Normal, 8.5-10.1 32 (94.1%)
Triglycerides, mg/dL 176.9 (84.4)
Desirable, <150 17 (50%)
Not desirable, ≥150 17 (50%)
Cholesterol, mg/dL 188.0 (39.3)
Desirable, 100 - 199.99 22 (64.7%)
Borderline High, 200 - 239.99 9 (26.5%)
High, >240 3 (8.8%)
HDL, mg/dL 46.5 (12.6)
Low, <40 11 (32.4%)
High, ≥60 3 (8.8%)
LDL, mg/dL 106.1 (38.1)
Normal, 40-189 32 (94.1%)
High, 190-263 2 (5.9%)
HbA1c, % 6.4 (.9)
Normal, 4.4-5.8%
Hemoglobin, g/dL 14.3 (.6)
Normal, 12.0-16.0
Hematocrit, % 41.6 (3.3)
Normal, 36-48 34 (100%)
T4, mcg/dL 8.3 (1.5)
Normal, 4.8-13.9 34 (100%)
TSH, mcIU/mL 3.2 (2.7)
Normal, .358-3.740 24 (70.6%)
APOE genotypeb
33 23 (67.6%)
34 10 (29.4%)
44 1 (2.9%)

a. 55% were fasted, 17.5% were of unknown fasting state, and 12.5% were not fasted.

b. Three participants did not consent to APOE genotyping. No e2 alleles were detected.